Aging
Introduction
Section titled “Introduction”Aging is a universal and multifaceted biological process characterized by a progressive decline in physiological function, leading to increased vulnerability to disease and ultimately death. This complex phenomenon is influenced by a combination of genetic, environmental, and lifestyle factors. Understanding the underlying mechanisms of aging is crucial for promoting health and well-being in an increasingly aging global population.
Biological Basis
Section titled “Biological Basis”At a biological level, aging involves a cascade of molecular and cellular changes. These include the accumulation of DNA damage, telomere attrition, epigenetic alterations (such as changes in DNA methylation patterns, often referred to as “epigenetic clocks”), loss of proteostasis, mitochondrial dysfunction, cellular senescence, and stem cell exhaustion. Research, often through genome-wide association studies (GWAS), has identified numerous genetic variants, or single nucleotide polymorphisms (SNPs), associated with various aspects of aging and longevity. For instance, studies have explored genetic correlates of longevity and age-related phenotypes.[1] identifying loci such as those on chromosomes 1, 6, 8 (including an exonic variant within LPL called rs268 ), 19 (including rs7412 in the APOE locus), and 20.[2]Other genes implicated in aging through GWAS includeOTOL1, BIN2, ATG4C, ORC5L, KCNQ4, MECOM, SUCLA2, and ST3GAL3.[3]Epigenetic age acceleration has also been identified as a biomarker of aging.[4]
Clinical Relevance
Section titled “Clinical Relevance”Aging is the primary risk factor for most chronic diseases, including cardiovascular disease, type 2 diabetes, neurodegenerative disorders, and various cancers.[5]Unraveling the genetic architecture of aging holds significant clinical relevance, as it can inform strategies for disease prevention and health promotion in middle-aged and older adults.[1]Identifying novel genetic loci and potential drug targets is a key goal in the pursuit of healthy aging.[2]which is broadly defined as the maintenance of well-being in old age, encompassing both the absence of disease and the presence of happiness, satisfaction, and fulfillment.[2]Genetic associations with components of healthy aging have been evaluated, particularly in diverse populations.[6]
Social Importance
Section titled “Social Importance”With a growing proportion of older adults worldwide, the social importance of understanding and addressing aging is paramount. Research into the genetics of aging aims to enhance understanding of the mechanisms responsible for aging, thereby identifying directions for interventions that allow older persons to enjoy more time in good health.[1]By extending healthspan—the period of life spent in good health—rather than merely lifespan, genetic insights can contribute to personalized approaches that reduce the societal burden of age-related diseases and improve the overall quality of life for an aging population.
Methodological and Statistical Considerations
Section titled “Methodological and Statistical Considerations”Many studies on aging, particularly those investigating polygenic traits, rely on large sample sizes often achieved through meta-analyses of multiple cohorts. However, even with such approaches, the overall sample size may still be considered small for comprehensive genome-wide analyses of highly complex phenotypes.[4] This limitation can reduce the statistical power to detect smaller genetic effects, potentially leading to an overestimation or inflation of effect sizes for the associations that are identified.[2]Furthermore, the inherent nature of some research, where predetermination of sample size, experimental randomization, or investigator blinding is not applicable, can introduce biases that impact the robustness and reproducibility of the findings.[2]The statistical models employed in genetic studies, such as multivariate GWAS, often assume an additive model for genetic variants, which may not fully capture the impact of recessive variants or more complex genetic interactions that could significantly influence aging.[2]Tests for heterogeneity, like QSNP analyses, can indicate instances where single nucleotide polymorphism (SNP) associations might act through pathways not fully encompassed by the multivariate framework, suggesting underlying biological complexities beyond the current model.[2] While genomic inflation in analyses is often attributable to polygenicity rather than population structure, careful distinction is necessary for accurate interpretation.[7] Consequently, the replication of identified genetic associations in diverse, independent cohorts remains a critical step to validate findings and strengthen their clinical and biological relevance.[1]
Generalizability and Phenotype Definition
Section titled “Generalizability and Phenotype Definition”A primary limitation in many current genome-wide association studies of aging-related traits is the predominant inclusion of participants solely of European ancestry.[4]This demographic restriction significantly constrains the generalizability of the study findings to populations of other ethnicities and ancestral backgrounds, given that epigenetic aging rates and underlying genetic architectures can vary considerably across different human populations.[4]Therefore, the identified genetic loci and their associations with aging phenotypes may not be universally applicable, underscoring the necessity for future research to validate these findings in more diverse cohorts as such data become available.[2]The conceptualization and of aging phenotypes also present inherent challenges. Multivariate GWAS, while effective for elucidating shared genetic structures across complex traits, often generate composite phenotypes, such as mvAge, that lack conventional, clinically interpretable units.[2] This absence of standard units can complicate the clinical interpretation of numerical estimates, particularly in Mendelian randomization analyses where lifelong estimates are derived.[2] Additionally, variations in how traits are measured across different studies, or the use of historical cohorts whose demographic characteristics and common causes of death may have changed over time, can introduce inconsistencies and impact the comparability and interpretation of meta-analyzed results.[4]
Complex Genetic Architecture and Environmental Influences
Section titled “Complex Genetic Architecture and Environmental Influences”The intricate process of aging is profoundly shaped by a dynamic interplay between an individual’s genetic makeup and their environmental exposures. Many studies, however, do not explicitly explore gene-environment interactions or epistasis, which are crucial for understanding how environmental factors can modify genetic associations and influence aging trajectories.[1]Uncontrolled environmental heterogeneity across study populations can introduce considerable noise into analyses, making it challenging to precisely delineate the genetic contributions to complex aging phenotypes.[8]A more comprehensive understanding of aging requires accounting for these multifaceted interactions, as environmental influences can significantly modulate genetic expression and disease susceptibility over the lifespan.
Despite considerable progress in identifying genetic loci associated with aging-related traits, a substantial portion of the heritability for these complex phenotypes remains unexplained, a phenomenon often referred to as “missing heritability”.[7] This gap suggests that current genetic models, which frequently assume simple additive effects, may not fully capture the complexity of genetic contributions, including the roles of rare variants or intricate gene-gene interactions.[2]Furthermore, significant challenges persist in translating genetic discoveries into effective clinical interventions, particularly for aging-related therapeutics, which typically demand lengthy study durations, very large sample sizes, and careful patient selection.[2]Continued investigation into the nuanced relationship between aging and age-related diseases is essential to bridge these knowledge gaps and facilitate the development of strategies that promote healthy aging and reduce disease burden.[2]
Variants
Section titled “Variants”Genetic variations play a crucial role in influencing the human aging process, affecting everything from cellular maintenance to susceptibility to age-related diseases. Among the most extensively studied is theAPOE gene, which is vital for the metabolism and transport of fats throughout the body and brain. The variant rs7412 , alongside rs429358 , defines the well-known APOE ε2, ε3, and ε4 alleles, with the ε4 allele being a significant genetic risk factor for Alzheimer’s disease and cardiovascular conditions, which are prevalent with advancing age.[9] Studies have consistently shown a strong association between APOEgenotype and human longevity, highlighting its influence on survival into old age, with the ε4 allele generally linked to reduced longevity and increased frailty.[10] Other variants impact fundamental cellular processes, such as those within the AXIN1 gene, a key scaffold protein in the Wnt signaling pathway that regulates cell proliferation, differentiation, and tissue homeostasis. Variants like rs76038336 , rs1057209 , and rs7206286 could potentially alter Wnt pathway activity, influencing cell fate and the maintenance of tissues throughout life, with dysregulation linked to age-related conditions like cancer and bone density loss.[3] Similarly, the FAM234A gene, with variants such as rs56007737 and rs740000 , is thought to play a role in membrane-associated cellular functions, while RGS11 (rs740000 ) is a regulator of G-protein signaling, critical for neuronal communication and sensory perception.[1] Variations in these genes could affect the efficiency of cellular transport, structural integrity, and the complex signaling networks that are essential for maintaining physiological balance and resilience against age-related decline.
Variants in genes involved in protein quality control and cellular stress responses also contribute to the aging landscape. TheNHLRC1 gene, encompassing rs10949481 and rs10949483 , encodes an E3 ubiquitin ligase, crucial for tagging damaged or misfolded proteins for degradation. Impaired function due to these variants could lead to the accumulation of toxic protein aggregates, a hallmark of many neurodegenerative diseases that manifest in later life.[4] The SH3YL1 gene (rs17713879 , rs71437291 ) is involved in membrane trafficking and cytoskeletal dynamics, processes vital for maintaining cellular structure and communication, which can become less efficient with age.[8] Additionally, RFX7 (rs8030605 ) acts as a transcription factor, potentially influencing immune function and inflammation, both of which are critical modulators of healthy aging and disease susceptibility.[11]Further genetic influences on aging can be seen in genes involved in stress response, gene expression, and even sensory perception. Variants in theCREB3L3 gene, such as rs73538174 , rs8103978 , and rs7257786 , are associated with the unfolded protein response and lipid metabolism, impacting how cells cope with stress and maintain metabolic health, factors that decline with age and contribute to metabolic disorders.[2] The LUC7L gene (rs966965120 ), involved in pre-mRNA splicing, can affect the accuracy of gene expression, which is known to diminish with age and contribute to cellular dysfunction.[12] Finally, a region containing HBG2, OR51I2, HBE1, and OR51B5 (rs11037480 ) includes genes for hemoglobin components and olfactory receptors. While globin genes are primarily active in development, subtle variations could affect systemic oxygen handling, while olfactory receptor genes impact the sense of smell, which often deteriorates significantly in older individuals, affecting quality of life and nutrition.[3]
Key Variants
Section titled “Key Variants”| RS ID | Gene | Related Traits |
|---|---|---|
| rs76038336 rs1057209 rs7206286 | AXIN1 | platelet count platelet volume aging hematocrit hemoglobin |
| rs966965120 | LUC7L - C4orf46P1 | aging |
| rs73538174 rs8103978 rs7257786 | Metazoa_SRP - CREB3L3 | aging |
| rs56007737 | FAM234A | aging |
| rs10949481 rs10949483 | NHLRC1 | aging |
| rs17713879 rs71437291 | SH3YL1 | diastolic blood pressure, systolic blood pressure smoking initiation triglyceride low molecular weight phosphotyrosine protein phosphatase proactivator polypeptide-like 1 |
| rs7412 | APOE | low density lipoprotein cholesterol clinical and behavioural ideal cardiovascular health total cholesterol reticulocyte count lipid |
| rs740000 | FAM234A, RGS11 | aging |
| rs8030605 | RFX7 | BMI-adjusted waist-hip ratio plasminogen activator inhibitor 1 aging waist-hip ratio |
| rs11037480 | HBG2, OR51I2, HBE1, OR51B5 | aging |
Classification, Definition, and Terminology of Aging
Section titled “Classification, Definition, and Terminology of Aging”Aging is a complex, multifaceted biological process characterized by the functional deterioration of multiple organs over time, leading to increased susceptibility to disease and mortality.[13]While chronological age (CA) denotes the time elapsed since birth, a more precise understanding of an individual’s physiological state is captured by biological age. The study of aging involves defining, classifying, and measuring these intricate processes to understand their impact on health and longevity.
Conceptualizing Aging: Chronological versus Biological Definitions
Section titled “Conceptualizing Aging: Chronological versus Biological Definitions”Aging, at its most fundamental, refers to the progressive decline in physiological integrity that results in impaired function and increased vulnerability to death. Chronological age, a simple metric of time, serves as a universal but often insufficient indicator of an individual’s true biological state, as individuals age at different rates.[14]To address this variability, the concept of biological age (BA) has emerged, defined as a term that estimates the rate and extent of biological aging and reflects the biological and physiological functions of individuals.[15]This distinction is crucial for identifying those at higher risk for age-related diseases and for developing targeted interventions to promote healthy aging. Healthy aging, a related concept, is operationally defined by a composite of criteria including the absence of chronic diseases, no cognitive impairment (assessed by scales like the Singapore-modified Mini-Mental Examination), no limitations in instrumental activities of daily living (using the Lawton IADL scale), no major depression (Geriatric Depression Scale score below 5), good self-perceived health, good physical functioning, and no self-reported function-limiting pain.[6]These precise definitions allow for a more nuanced classification of aging phenotypes beyond mere chronological years.
Classification and Operationalization of Biological Age Models
Section titled “Classification and Operationalization of Biological Age Models”The classification of biological aging extends beyond a singular definition, encompassing various models designed to quantify its rate and extent. Several biological age models have been proposed, including the frailty index, Phenotypic Age (PhenoAge), Klemera-Doubal method Biological Age (KDM-BA), and epigenetic PhenoAge.[16]PhenoAge, for instance, was developed using clinical data and incorporates composite routine clinical haematology and chemistry biomarkers, optimized to differentiate mortality risk among persons of the same chronological age.[11]Another measure, BioAge, is based on chronological age and a distinct set of seven biomarkers, also trained for mortality prediction.[11]These models represent categorical or dimensional approaches to classifying aging, moving beyond simple presence or absence of disease to a spectrum of biological decline, and are crucial for understanding the burden of age-related diseases, which are increasing rapidly and are major causes of mortality and morbidity.[17]The development of such models often utilizes conceptual frameworks like the Gompertz mortality model to parametrize biomarker contributions.[11]
Approaches and Key Biomarkers
Section titled “Approaches and Key Biomarkers”The diagnostic and criteria for biological age models are diverse, integrating a wide array of clinical, biochemical, and omics data. PhenoAge, for example, is calculated using a formula derived from biomarkers such as albumin, creatinine, glucose, C-reactive protein (CRP), lymphocyte percent, mean red cell volume, red cell distribution width, alkaline phosphatase, and white blood cell count.[11]Similarly, BioAge incorporates albumin, alkaline phosphatase, creatinine, C-reactive protein, glycated hemoglobin (HbA1c), systolic blood pressure (SBP), and total cholesterol.[11]Beyond these specific models, broader biological age assessments may include physical measures like hand grip strength, fat mass, pulse rate, FVC, FEV1, and derived variables such as pulse pressure (PP), mean arterial pressure (MAP), and waist-hip ratio (WHR).[16]Further, metabolic markers like serum folate, vitamin B12, other vitamins (thiamine, riboflavin, nicotinamide, pyridoxal phosphate, vitamin D, all-trans retinol, alpha tocopherol, gamma tocopherol), one-carbon pathway metabolites (homocysteine, methionine, betaine, choline, dimethylglycine, cystathionine, cysteine), and tryptophan metabolites (tryptophan, kynurenine) are also measured to provide comprehensive insights into an individual’s biological state.[11]These quantitative traits, along with cognitive functions and indicators of renal function (e.g., eGFR, urea, potassium in urine), serve as critical biomarkers and thresholds for assessing the rate of physiological aging and identifying potential targets for interventions.[16]
Signs and Symptoms
Section titled “Signs and Symptoms”The aging process is characterized by a complex array of clinical manifestations and physiological changes that vary significantly among individuals. These signs and symptoms are assessed through a combination of objective measurements, molecular biomarkers, and composite scores designed to capture an individual’s biological age rather than merely their chronological age. The heterogeneity of aging necessitates diverse approaches to account for inter-individual variability, sex differences, and the nuanced presentation of age-related phenotypes.
Clinical Manifestations and Physiological Assessments
Section titled “Clinical Manifestations and Physiological Assessments”Aging clinically manifests through a range of physiological changes, including alterations in body composition, metabolic function, and organ system performance. Typical signs encompass changes in body mass index (BMI), blood pressure, and reductions in physical capabilities such as hand grip strength and lung function.[8]These physiological parameters serve as key indicators, with their assessment involving direct clinical measurements. For example, blood pressure is routinely measured, while hand grip strength and lung function are assessed using specific devices.[8]Longitudinal fundus imaging is also employed to track age-related changes in the retina, providing evidence for a human retinal aging clock.[7]The patterns of these clinical presentations vary significantly among individuals, reflecting the inherent heterogeneity of the aging process. While some individuals may experience a gradual decline across multiple systems, others might show accelerated deterioration in specific areas, leading to diverse clinical phenotypes.[11]These variations highlight the importance of objective measures in quantifying age-related changes and their diagnostic significance in identifying individuals with accelerated biological aging. Such measures, when integrated, contribute to comprehensive assessments that help differentiate typical age-related changes from more severe or atypical presentations, offering insights into an individual’s overall physiological aging rate.[8]
Biomarkers and Molecular Signatures
Section titled “Biomarkers and Molecular Signatures”Biological aging is characterized by a complex interplay of molecular and biochemical changes, detectable through various biomarkers. Common blood biomarkers include C-reactive protein (ln(CRP)), white blood cell count, alkaline phosphatase, fasting glucose, albumin, and creatinine.[11] These are typically measured in plasma or serum using automated laboratory platforms.[11]For instance, ln(CRP) shows strong correlations with adiposity measures, glycaemic traits, and lipid species, while fasting glucose is primarily associated with glycaemic traits and adiposity.[11] Albumin levels correlate with fat mass, and creatinine with IGFBP-6.[11]Beyond these, a broader panel of blood biomarkers encompasses lipid profiles (triglyceride, total cholesterol, HDL-cholesterol), liver enzymes (alanine transaminase, aspartate transaminase, gamma-glutamyl transferase), glycaemic measures, vitamins, metabolites, growth factors, fatty acids, amino acids, and other protein biomarkers.[11]Multi-omics approaches further refine the understanding of aging’s molecular signatures, incorporating data from genomics, lipidomics, and the gut microbiome.[11] Genetic variants, such as those in genes like ZDHHC19, SIRPA, and PMEPA1, have been identified through genome-wide association studies (GWAS) as being associated with aging processes.[11] Additionally, missense mutations in genes like NOX4, IL4R, DEFB128, DEFB127, and ACSBG2are linked to accelerated phenotypic aging.[11]These molecular markers, alongside telomere length and metabolomics-based scores, provide objective measures that are crucial for developing comprehensive biological aging clocks and offer significant diagnostic and prognostic value in assessing an individual’s biological age and potential for future morbidity and mortality.[11]
Composite Aging Metrics and Predictive Models
Section titled “Composite Aging Metrics and Predictive Models”The concept of biological aging often extends beyond chronological age, incorporating composite metrics and predictive models to capture an individual’s true physiological state. Phenotypic Age (PhenoAge) is one such composite measure, calculated using chronological age and a panel of nine clinical biomarkers.[11] PhenoAge Acceleration (PhenoAgeAccel), derived as the residual from regressing PhenoAge on chronological age, quantifies how much an individual’s biological age deviates from their chronological age.[11]This metric is crucial for identifying individuals exhibiting accelerated biological aging, where a positive PhenoAgeAccel indicates an older biological age relative to chronological age, and vice versa.[11] While PhenoAge provides a quantitative measure, other approaches like epigenetic clocks and telomere length also serve as biological age predictors.[11]Significant inter-individual variability and heterogeneity characterize the aging process, with some individuals showing a faster pace of aging than others, even within the same chronological age group.[11] For instance, women typically live longer and may have lower biological ages than men, yet paradoxically, they often experience poorer health in later life.[11]Machine learning algorithms are increasingly utilized to predict physiological aging rates from a broad range of quantitative traits, including physiological measures and blood molecular markers, improving the predictive accuracy of aging models.[8]These composite measures and predictive models hold substantial diagnostic significance as they demonstrate superior predictive performance for morbidity and mortality compared to single biomarkers, acting as important prognostic indicators and potentially identifying “red flags” for early intervention strategies.[11]
Causes of Aging
Section titled “Causes of Aging”Aging is a complex biological process influenced by an intricate interplay of genetic predispositions, epigenetic modifications, environmental exposures, and lifestyle choices, ultimately leading to a progressive decline in physiological function and increased susceptibility to disease. Understanding these multifaceted causal factors is crucial for developing interventions aimed at promoting healthy aging.[1]
Genetic Predisposition and Inheritance
Section titled “Genetic Predisposition and Inheritance”An individual’s genetic makeup significantly contributes to their rate of biological aging. Genome-wide association studies (GWAS) have identified numerous genetic loci associated with various aging-related traits, including longevity, healthspan, and parental lifespan.[18]These studies reveal a polygenic architecture where numerous inherited variants, rather than a single gene, collectively influence the aging process. Specific single nucleotide polymorphisms (SNPs) have been linked to factors associated with biological aging, such asrs9864994 in ZDHHC19 influencing IGF-1 and IGF-2 levels, rs112608975 in SIRPAaffecting thiamine and phenylalanine, andrs157092 in PMEPA1associated with fat mass and liver fat.[11] Other variants, such as rs78438918 , rs114298671 , and rs6062322 , have been associated with cognition and body mass index, further illustrating the broad genetic influence on diverse aging-related processes.[2]The genetic architecture of aging involves shared components across different aging-related traits, with some genetic factors influencing lifespan and longevity, while others are more closely linked to healthspan, frailty, and epigenetic age acceleration.[2]
Epigenetic and Developmental Influences
Section titled “Epigenetic and Developmental Influences”Beyond inherited genetic sequences, epigenetic modifications, particularly DNA methylation (DNAm), play a critical role in regulating biological aging. DNAm involves the addition of a methyl group to cytosine-guanine dinucleotides (CpG) and is a dynamic process influenced by both genetic and environmental factors throughout an individual’s life.[19]The overall decline in genomic DNA methylation is observed with advancing age.[20]DNA methylation patterns are used to construct “epigenetic clocks,” which are powerful biomarkers that can predict biological age and even all-cause mortality, often exhibiting an “epigenetic age acceleration” that reflects a faster biological aging rate than chronological age.[19]While direct evidence of early life developmental factors influencing aging through these specific mechanisms is not extensively detailed, the concept of “epigenetic drift over the human life course” highlights that cumulative epigenetic changes from conception onward contribute to the aging phenotype.[21]
Environmental and Lifestyle Factors
Section titled “Environmental and Lifestyle Factors”External factors from the environment and individual lifestyle choices are significant drivers of biological aging. Modifiable lifestyle factors such as diet, exercise, smoking, and obesity are known to influence the rate of biological aging, partly through their effects on DNA methylation patterns.[12]For instance, specific dietary patterns like the Healthy Eating Index (HEI) score have been inversely associated with markers of accelerated biological aging.[11]Environmental exposures can also directly alter tissue-specific DNA methylation, particularly in CpG island contexts, indicating a direct epigenetic pathway through which the environment influences aging.[22]Furthermore, broader environmental associations, including socioeconomic and geographic influences, contribute to variations in biological aging, although the precise mechanisms require further investigation.[23]
Interplay of Factors and Health Comorbidities
Section titled “Interplay of Factors and Health Comorbidities”The aging process is not solely driven by isolated factors but emerges from complex interactions between genetic predispositions and environmental exposures. These gene-environment interactions mean that an individual’s genetic susceptibility can be modulated by their lifestyle and environment, influencing their biological aging trajectory.[22]Moreover, aging itself is a primary risk factor for a multitude of diseases, and age-related biological dysregulation contributes significantly to the onset and progression of many chronic conditions.[5]Various clinical measurements and biomarkers, such as adiposity measures, C-reactive protein (CRP), white blood cell count, alkaline phosphatase, fasting glucose, and specific lipid species, are strongly correlated with accelerated biological aging and often reflect underlying comorbidities.[11]The investigation of existing therapies and potential drug targets for anti-aging therapeutics further highlights that medication effects and interventions can modify the aging process.[2]
Biological Background of Aging
Section titled “Biological Background of Aging”Aging is a multifaceted biological process characterized by the progressive decline of physiological functions and regenerative capacity across various tissues and organs, leading to increased susceptibility to disease and ultimately, death.[11]While chronological age progresses uniformly for everyone, individuals exhibit considerable variability in their biological aging rate, influencing health outcomes and lifespan.[14]Understanding the intricate molecular, cellular, and systemic mechanisms underlying aging is crucial for developing strategies to promote healthy longevity and mitigate the burden of age-related diseases.[16]
Cellular and Molecular Hallmarks of Aging
Section titled “Cellular and Molecular Hallmarks of Aging”At the cellular and molecular levels, aging is marked by several interconnected hallmarks that drive functional decline. These include genomic instability, chronic inflammation, cellular senescence, and mitochondrial dysfunction.[11] Processes like apoptosis (programmed cell death) and autophagy (cellular self-cleaning) are vital for cellular health, and genes such as FAIM and TERTare linked to their regulation during aging.[4] For instance, CISD2is a fundamentally important regulator of lifespan that controls autophagy and has been shown in mouse studies to ameliorate age-associated degeneration in tissues like skin, skeletal muscle, and neurons, while protecting mitochondria from damage and functional decline.[4]Furthermore, neurons are particularly vulnerable to damage caused by reactive oxygen species, and limitations in cellular maintenance and repair mechanisms can reinforce these damaging pathways, accelerating the aging process.[3]
Genetic and Epigenetic Regulation of Longevity
Section titled “Genetic and Epigenetic Regulation of Longevity”Genetic factors play a significant role in determining an individual’s rate of biological aging and longevity. Specific genes likeAPOE and FOXO3Ahave been associated with human aging and the ability to reach extreme old age.[3]Beyond direct gene sequences, epigenetic modifications, especially DNA methylation, profoundly influence gene expression patterns throughout the lifespan.[12]DNA methylation involves the addition of a methyl group to cytosine-guanine dinucleotides (CpGs) and forms the basis for “epigenetic clocks,” which are powerful biomarkers that can predict an individual’s biological age, health outcomes, and even all-cause mortality.[24]These epigenetic patterns are influenced by both genetic predispositions and environmental factors, including diet, exercise, and lifestyle.[12] Other regulatory elements, such as long noncoding RNAs, also contribute to the complex gene expression changes observed with age in various tissues, including blood, skin, adipose tissue, and the brain.[25]
Systemic Interplay and Organ-Specific Vulnerabilities
Section titled “Systemic Interplay and Organ-Specific Vulnerabilities”Aging represents a systemic decline, impacting the physiological functions and regenerative potential of multiple organs and tissues.[16]The brain is considered a central coordinator of physiological changes associated with aging, with neurological pathways potentially interacting with known candidate genes involved in the process.[3]Neurons, in particular, are susceptible to damage, which can accelerate cognitive aging and influence lifespan.[3] The immune system also undergoes significant age-related changes, leading to immunodeficiency characterized by a shortage of circulating naive CD8(+) T cells, making older individuals more vulnerable to infections and diseases.[26] Furthermore, homeostatic disruptions such as altered Wntsignaling during aging can impact tissue-specific stem cell fates, contributing to increased fibrosis and impaired regeneration in muscle.[27]Deregulated hormonal signaling with age is another systemic consequence that can be influenced by the ability of neuronal cells to prevent or repair oxidative damage, potentially delaying age-related disease onset.[3]
Metabolic Pathways and Their Influence on Aging
Section titled “Metabolic Pathways and Their Influence on Aging”Metabolic processes and their associated signaling pathways are critically involved in regulating the pace of aging. Key pathways, such as the mTOR pathway, insulin and insulin-like growth factor signaling, and lipoprotein metabolism, are all implicated in influencing longevity.[3] For example, the gene PIK3CBplays a role in the signal transduction of insulin and insulin-like pathways, and genetic variants at this locus have been linked to plasma insulin-like growth factor levels and human longevity.[4]Disruptions in energy metabolism, alongside chronic inflammation and immune responses, are often reflected in changes in blood biomarkers and are recognized as modifiable factors influencing accelerated biological aging.[11]Beyond intrinsic cellular metabolism, the gut microbiome is also emerging as a significant factor in biological aging, with its composition and function influencing systemic metabolic and immune processes.[11]
Core Cellular Regulation and Lifespan Control
Section titled “Core Cellular Regulation and Lifespan Control”Aging involves intricate cellular signaling cascades that modulate fundamental biological processes. For instance,PIK3CBplays a crucial role in the signal transduction of insulin and insulin-like pathways, which are vital for coordinating cell functions and have been linked to human longevity.[4] These pathways often involve receptor activation leading to intracellular signaling cascades that ultimately regulate transcription factors, influencing gene expression patterns critical for cell maintenance and repair.[28]Dysregulation within these finely tuned feedback loops contributes to the hallmarks of aging, including epigenetic alterations and genomic instability.[11]Key regulatory mechanisms such as autophagy and apoptosis are directly implicated in the aging process. Genes likeFAIM and TERT are associated with apoptosis and autophagy, while CISD2 is a fundamental regulator of lifespan that controls autophagy.[4] CISD2also protects mitochondria from age-related damage and functional decline, with its deficiency leading to phenotypic features suggestive of premature aging.[4]These processes involve complex protein modifications and post-translational regulation, ensuring cellular quality control and influencing cellular senescence, a hallmark of aging.[11]
Metabolic Homeostasis and Mitochondrial Function
Section titled “Metabolic Homeostasis and Mitochondrial Function”Aging is profoundly influenced by the integrity of metabolic pathways, which govern energy metabolism, biosynthesis, and catabolism. Genes such asMANBA and UBE2D3 have roles in both metabolic and immune system functions, highlighting the interconnectedness of these systems in maintaining homeostasis.[4] Effective metabolic regulation and flux control are essential for cellular vitality, as evidenced by CISD2’s ability to attenuate age-associated reductions in energy metabolism.[4]Disruptions in these pathways, including those affecting insulin and insulin-like growth factor (IGF) signaling, are central to age-related decline.[3], [4]Mitochondrial function is a critical component of metabolic homeostasis, and its decline is a recognized hallmark of aging.[11]The protection of mitochondria from age-related damage and functional decline, partly regulated by factors likeCISD2, is crucial for preventing premature aging.[4]Furthermore, altered sphingolipid function and variations in metabolic pathways influencing lipid profiles, such as HDL-cholesterol, underscore the complex metabolic dysregulations associated with aging and disease susceptibility.[29], [30]Blood biomarkers related to nutritional and energy metabolism, including fasting glucose and IGF-1, serve as key indicators of these age-related metabolic shifts.[11]
Immune and Neuro-Regulatory Pathways
Section titled “Immune and Neuro-Regulatory Pathways”The immune system undergoes significant changes with age, commonly referred to as immune system aging, characterized by chronic inflammation and immunodeficiency.[11], [26], [31] Specific innate immune system pathways, involving genes like TRIM46 and MUC1, are implicated in this process.[4] The interplay between metabolic and immune system functions, exemplified by genes such as MANBA and UBE2D3, highlights how systemic shifts in one system can impact the other, collectively contributing to age-related vulnerabilities.[4] Blood biomarkers related to inflammation and immune response are key indicators of these systemic changes.[11]Neurological pathways play a critical role in the coordination of physiological changes throughout the aging process, with the brain potentially serving as a central regulator.[3]Neurons are particularly susceptible to damage caused by reactive oxygen species, and limitations in cellular maintenance and repair mechanisms can reinforce these pathways, accelerating aging.[3] Factors such as MTRNR2L7, which acts as a neuroprotective and anti-apoptotic factor, are crucial in maintaining neuronal health.[4]An increased capacity of neuronal cells to prevent or repair oxidative damage can lead to beneficial hormonal signaling, potentially delaying age-related diseases and directly regulating cognitive aging and lifespan.[3]
Interconnected Networks and Systemic Aging
Section titled “Interconnected Networks and Systemic Aging”Aging is an emergent property of complex biological systems, resulting from intricate pathway crosstalk and network interactions across multiple physiological domains.[8], [32]Neurological pathways, for example, interact significantly with established candidate genes involved in aging, suggesting a hierarchical regulation where the brain may coordinate many physiological changes.[3]This systemic integration is evident in the complex interconnections observed between clinical factors, blood biomarkers, lipids, genetic variants, and the gut microbiome, all collectively contributing to the overall biological aging process.[11]Dysregulation within these integrated networks underlies many age-related diseases, as aging itself is a major risk factor.[5]For instance, blood biomarkers related to inflammation, immune response, and energy metabolism can mediate the associations of diet, adiposity, genetic variants, and gut microbial species with accelerated biological aging.[11]Understanding these widespread pathway dysregulations and identifying potential compensatory mechanisms is critical for developing therapeutic targets aimed at mitigating accelerated aging and its associated pathologies.[11]
Prognosis and Risk Stratification
Section titled “Prognosis and Risk Stratification”Understanding the aging process and its biological markers holds significant prognostic value, enabling predictions of health outcomes, disease progression, and long-term implications for patient care. Biological age, which can deviate from chronological age, serves as a more accurate predictor of morbidity and mortality across diverse populations.[16]For instance, the “age gap” (the difference between biological and chronological age) is significantly associated with common health-related outcomes, identifying individuals at higher risk for adverse events, including chronic obstructive pulmonary disease (COPD) and myocardial infarction.[7] Measures like epigenetic age acceleration and phenotypic age acceleration (PhenoAgeAccel) are crucial in identifying high-risk individuals, as they correlate with various clinical measurements and biomarkers, highlighting those who may benefit most from early preventative strategies.[11] Furthermore, specific genetic variants identified through genome-wide association studies (GWAS) can predict the risk of dying or experiencing major health events, allowing for personalized risk stratification and targeted interventions.[3]Another innovative approach, the retinal aging clock (eyeAge) derived from longitudinal fundus imaging, offers additional prognostic insights. eyeAgeis statistically associated with mortality risk, even after adjusting for chronological age and other biological age markers likePhenoAge, suggesting its independent utility.[7] This metric also shows nominally significant associations with chronic diseases such as COPD and myocardial infarction, indicating its potential for identifying individuals predisposed to specific age-related conditions.[7]By integrating these diverse biological age indicators and genetic insights, clinicians can move towards a personalized medicine approach, tailoring prevention strategies and monitoring plans to individuals based on their unique biological aging profiles and identified genetic predispositions.[1]
Diagnostic Utility and Personalized Interventions
Section titled “Diagnostic Utility and Personalized Interventions”The comprehensive analysis of aging-related traits offers substantial diagnostic utility and guides personalized intervention strategies. Multi-omics data, including clinical measurements, blood biomarkers, lipids, genetic variants, and gut microbial species, are being explored to understand accelerated biological aging.[11] For example, ln(CRP)(C-reactive protein), white blood cell count, and alkaline phosphatase are strongly correlated with various aging-related factors such as adiposity, glycaemic traits, and lipid species, providing valuable diagnostic markers for accelerated aging.[11]Machine learning models are also being developed to predict physiological aging rates from a range of quantitative traits, enhancing diagnostic accuracy and enabling early identification of physiological decline.[8]Beyond diagnostics, this research facilitates the selection of targeted treatments and the development of monitoring strategies. Mendelian randomization (MR) studies identify modifiable risk factors and biomarkers that support healthy aging initiatives, guiding lifestyle and pharmacological interventions.[2] Drug-target MR is particularly promising, investigating therapeutic repurposing opportunities for existing medications like metformin, other antidiabetic classes, lipid-lowering therapies, and antihypertensive drugs, by linking genetic evidence to potential drug targets.[2]This approach aims to identify protein-coding genes that could serve as novel therapeutic targets to improve healthy aging, supporting the development of precision medicine tailored to an individual’s genetic and biological aging profile.[2]
Comorbidities and Disease Associations
Section titled “Comorbidities and Disease Associations”Aging is a primary risk factor for a multitude of diseases, leading to a complex web of comorbidities and overlapping phenotypes that are critical for clinical consideration.[5]Research consistently demonstrates strong associations between biological aging measures and a wide range of health outcomes, including chronic diseases, cognitive decline, and increased frailty.[7]For instance, accelerated biological aging, as measured byPhenoAgeAccel, shows significant correlations with metabolic factors like adiposity measures, glycaemic traits, and lipid species, highlighting the interconnectedness of aging with metabolic syndrome and cardiovascular risk.[11]Genetic studies further reveal the shared genetic architecture between various aging-related traits and diseases.
Multivariate genome-wide analyses identify novel genetic loci that broadly impact healthy aging processes, influencing factors such as cognition, BMI, and hypertension, which are themselves common comorbidities in older adults.[2] Specific genes like MAGI3, LPL, and the APOE locus (rs7412 ) have been linked to these complex traits, providing insights into the molecular pathways underlying age-related conditions.[2]The overlap in genetic associations between different aging phenotypes, such as time to death and time to event analyses, also points to common biological mechanisms contributing to various age-related complications.[3]Understanding these systemic associations and overlapping phenotypes is crucial for developing comprehensive management plans that address the multi-faceted health challenges faced by aging populations.
Frequently Asked Questions About Aging
Section titled “Frequently Asked Questions About Aging”These questions address the most important and specific aspects of aging based on current genetic research.
1. My parents lived long; will I also age well?
Section titled “1. My parents lived long; will I also age well?”Yes, your family history suggests a genetic advantage for healthy aging. Studies have identified genetic loci, like those nearAPOE (rs7412 ) and LPL (rs268 ), that are associated with longevity and a reduced risk of age-related diseases. While not a guarantee, inheriting these protective variants can increase your likelihood of aging well.
2. Why do some people look older than their actual age?
Section titled “2. Why do some people look older than their actual age?”How old you look can be influenced by your “biological age,” which might differ from your chronological age. Epigenetic alterations, often referred to as “epigenetic clocks,” can measure this internal aging, and “epigenetic age acceleration” has been identified as a biomarker. These internal biological changes, influenced by genetics and environment, can sometimes manifest as visible signs of aging.
3. Can my daily habits really slow down my body’s aging process?
Section titled “3. Can my daily habits really slow down my body’s aging process?”Absolutely. While your genetics play a role, environmental and lifestyle factors are crucial in how you age. Healthy habits can positively influence molecular and cellular changes, such as reducing DNA damage accumulation or improving mitochondrial function, which are key aspects of the aging process. This can extend your “healthspan”—the period of life spent in good health.
4. Will I definitely get my family’s age-related diseases?
Section titled “4. Will I definitely get my family’s age-related diseases?”Not necessarily. Aging is the primary risk factor for many chronic diseases like cardiovascular conditions and neurodegenerative disorders, and your genetics do contribute to your susceptibility. However, understanding your genetic predispositions can inform prevention strategies, and lifestyle choices can significantly impact whether these genetic risks develop into actual diseases.
5. Is a genetic test useful to see how I might age?
Section titled “5. Is a genetic test useful to see how I might age?”Genetic tests can identify variants (SNPs) associated with various aspects of aging and longevity, such as those in genes likeOTOL1 or KCNQ4. While these can offer insights into your predispositions, interpreting complex aging phenotypes is still evolving. Current studies also often have limitations in generalizability, especially for populations outside of European ancestry.
6. Does my ethnic background affect how I might age?
Section titled “6. Does my ethnic background affect how I might age?”Yes, it can. Epigenetic aging rates and the underlying genetic architectures can vary considerably across different human populations. Many genetic studies on aging have predominantly included participants of European ancestry, meaning that identified genetic loci and their associations might not be universally applicable to other ethnicities.
7. Can I really extend the healthy part of my life, not just live longer?
Section titled “7. Can I really extend the healthy part of my life, not just live longer?”Yes, that’s a primary focus of modern aging research, aiming to extend “healthspan” rather than just lifespan. Genetic insights are helping to identify interventions that allow people to enjoy more time in good health, encompassing well-being, the absence of disease, and overall happiness and fulfillment in old age.
8. Why do some people seem to age much faster than others?
Section titled “8. Why do some people seem to age much faster than others?”The rate at which our bodies age internally, known as biological aging, varies significantly between individuals. This difference is influenced by a complex interplay of your genetic makeup, environmental exposures, and lifestyle factors that affect molecular processes like DNA damage and telomere attrition. Epigenetic clocks can even measure this accelerated biological aging.
9. Can what I eat affect my ‘biological age’?
Section titled “9. Can what I eat affect my ‘biological age’?”Yes, your dietary habits are a significant environmental factor influencing your biological age. Lifestyle choices, including diet, can impact epigenetic alterations (like DNA methylation patterns), mitochondrial function, and cellular senescence, all of which contribute to your body’s internal aging processes. Making healthy food choices can help promote a younger biological age.
10. Why do some people stay active and healthy well into old age?
Section titled “10. Why do some people stay active and healthy well into old age?”Staying active and healthy in old age is a complex outcome of both your genetic architecture and your lifelong environmental and lifestyle factors. Research into “healthy aging” aims to understand these influences, identifying genetic loci and pathways that contribute to maintaining well-being, the absence of disease, and overall satisfaction and fulfillment during later years.
This FAQ was automatically generated based on current genetic research and may be updated as new information becomes available.
Disclaimer: This information is for educational purposes only and should not be used as a substitute for professional medical advice. Always consult with a healthcare provider for personalized medical guidance.
References
Section titled “References”[1] Lunetta KL, et al. Genetic correlates of longevity and selected age-related phenotypes: a genome-wide association study in the Framingham Study. BMC Med Genet. 2007;8(Suppl 1):S13.
[2] Rosoff DB, et al. Multivariate genome-wide analysis of aging-related traits identifies novel loci and new drug targets for healthy aging.Nat Aging. 2023;2(8):723–736.
[3] Walter S, et al. A genome-wide association study of aging.Neurobiol Aging. 2011;32(10):1825-1839.
[4] Gibson J, et al. A meta-analysis of genome-wide association studies of epigenetic age acceleration. PLoS Genet. 2019;15(11):e1008491.
[5] Niccoli, T. and L. Partridge. “Ageing as a Risk Factor for Disease.”Curr Biol, 2012.
[6] Chang, X, et al. “Genetic associations with healthy ageing among Chinese adults.” NPJ Aging, vol. 5, no. 1, 4 Aug. 2022, p. 19. PubMed, PMID: 35927272.
[7] Ahadi, S, et al. “Longitudinal fundus imaging and its genome-wide association analysis provide evidence for a human retinal aging clock.”Elife, 17 Apr. 2023. PubMed, PMID: 36975205.
[8] Sun ED, et al. Predicting physiological aging rates from a range of quantitative traits using machine learning.Aging (Albany NY). 2021;13(20):23696-23719.
[9] Deelen J, et al. Genome-wide association study identifies a single major locus contributing to survival into old age; the APOE locus revisited. Aging Cell. 2011;10.1111/j.1474-9726.2011.00705.x.
[10] Nebel A, et al. A genome-wide association study confirms APOE as the major gene influencing survival in long-lived individuals. Mech Ageing Dev. 2011;132:324–330.
[11] Chen L, et al. Exploring multi-omics and clinical characteristics linked to accelerated biological aging in Asian women of reproductive age: insights from the S-PRESTO study.Genome Med. 2024;16(1):128.
[12] McCartney DL, et al. Genome-wide association studies identify 137 genetic loci for DNA methylation biomarkers of aging.Genome Biol. 2021;22(1):194.
[13] Hernandez-Segura, A. et al. “Hallmarks of cellular senescence.” Cell Death & Disease, 2018.
[14] Hamczyk, M. R. et al. “Aging and the cardiovascular system: molecular mechanisms and clinical implications.”Journal of the American College of Cardiology, 2020.
[15] Khan, S. S. et al. “Association of biological age with health outcomes and its modifiable factors.” Aging Cell, 2017.
[16] Liu, W. S. et al. “Association of biological age with health outcomes and its modifiable factors.” Aging Cell, 2023.
[17] GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. “Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017.”The Lancet, 2018.
[18] Brooks-Wilson, A. R. “Genetics of healthy aging and longevity.”Hum Genet, vol. 132, 2013, pp. 1323–1338.
[19] Horvath, S. and Raj, K. “DNA methylation-based biomarkers and the epigenetic clock theory of ageing.”Nat Rev Genet, vol. 19, no. 6, 2018, pp. 371–84.
[20] Bollati, V. et al. “Decline in genomic DNA methylation through aging in a cohort of elderly subjects.”Mech Ageing Dev, vol. 130, no. 4, 2009, pp. 234–9.
[21] Shah, S. et al. “Genetic and environmental exposures constrain epigenetic drift over the human life course.” Genome Res, vol. 24, no. 11, 2014, pp. 1725–33.
[22] Christensen, B. C. et al. “Aging and Environmental Exposures Alter Tissue-Specific DNA Methylation Dependent upon CpG Island Context.”PLoS Genet, vol. 5, no. 8, 2009, p. e1000602.
[23] Capobianco, E. et al. “Exploring domains, clinical implications and environmental associations of a deep learning marker of biological ageing.” European Journal of Epidemiology, vol. 37, 2022, pp. 35–48.
[24] Marioni, R. E. et al. “DNA methylation age of blood predicts all-cause mortality in later life.”Genome Biol, vol. 16, no. 1, 2015, p. 25.
[25] Glass, D., et al. “Gene expression changes with age in skin, adipose tissue, blood and brain.” Genome Biology, vol. 14, 2013, R75.
[26] Fagnoni, F. F., et al. “Shortage of circulating naive CD8(+) T cells provides new insights on immunodeficiency in aging.”Blood, vol. 95, no. 9, 2000, pp. 2860-2868.
[27] Brack, A. S., et al. “Increased Wnt signaling during aging alters muscle stem cell fate and increases fibrosis.”Science, vol. 317, no. 5839, 2007, pp. 807–10.
[28] Iwasaki, O., et al. “Involvement of condensin in cellular senescence through gene regulation and compartmental reorganization.” Nature Communications, vol. 10, no. 1, 2019, p. 5688.
[29] Dong, Q., et al. “Genome-wide association studies identify novel genetic loci for DNA methylation biomarkers of aging among survivors of childhood cancer.”Genome Medicine, vol. 14, no. 1, 2022, p. 30.
[30] Giovagnoni, C., et al. “Altered sphingolipid function in Alzheimer’s disease; a gene regulatory network.”Molecular Psychiatry, 2019, 24:431–46.
[31] Miller, R. A. “The aging immune system: primer and prospectus.”Science, vol. 273, no. 5271, 1996, pp. 70-74.
[32] Vural, D. C., et al. “Aging in complex interdependency networks.”Physical Review E, vol. 89, no. 2, 2014, p. 022811.